- Home
- ASM vs ORGO Comparison
ASM vs ORGO Comparison
Compare ASM & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASM
- ORGO
- Stock Information
- Founded
- ASM 1968
- ORGO 1985
- Country
- ASM Canada
- ORGO United States
- Employees
- ASM N/A
- ORGO N/A
- Industry
- ASM Metal Mining
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ASM Basic Materials
- ORGO Health Care
- Exchange
- ASM Nasdaq
- ORGO Nasdaq
- Market Cap
- ASM 612.8M
- ORGO 465.6M
- IPO Year
- ASM N/A
- ORGO N/A
- Fundamental
- Price
- ASM $3.17
- ORGO $4.66
- Analyst Decision
- ASM Buy
- ORGO Buy
- Analyst Count
- ASM 2
- ORGO 2
- Target Price
- ASM $3.15
- ORGO $6.50
- AVG Volume (30 Days)
- ASM 5.6M
- ORGO 836.9K
- Earning Date
- ASM 08-13-2025
- ORGO 08-07-2025
- Dividend Yield
- ASM N/A
- ORGO N/A
- EPS Growth
- ASM 715.13
- ORGO N/A
- EPS
- ASM 0.10
- ORGO N/A
- Revenue
- ASM $72,621,000.00
- ORGO $458,760,000.00
- Revenue This Year
- ASM $22.93
- ORGO $3.50
- Revenue Next Year
- ASM $25.22
- ORGO $8.59
- P/E Ratio
- ASM $37.85
- ORGO N/A
- Revenue Growth
- ASM 56.32
- ORGO 5.35
- 52 Week Low
- ASM $0.83
- ORGO $2.28
- 52 Week High
- ASM $4.41
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- ASM 38.48
- ORGO 56.98
- Support Level
- ASM $3.23
- ORGO $4.67
- Resistance Level
- ASM $4.41
- ORGO $5.15
- Average True Range (ATR)
- ASM 0.24
- ORGO 0.28
- MACD
- ASM -0.09
- ORGO -0.00
- Stochastic Oscillator
- ASM 3.12
- ORGO 64.59
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.